Company profile ORTX
There is not enough data for Orchard Therapeutics gene therapy to provide analysis
There is not enough data for Orchard Therapeutics gene therapy to provide correlation calculation
There is not enough data for Orchard Therapeutics gene therapy to provide analysis
There is not enough data for Libmeldy gene therapy to provide analysis
There is not enough data for Libmeldy gene therapy to provide correlation calculation
There is not enough data for Libmeldy gene therapy to provide analysis
There is not enough data for Strimvelis gene therapy to provide analysis
There is not enough data for Strimvelis gene therapy to provide correlation calculation
There is not enough data for Strimvelis gene therapy to provide analysis
There is not enough data for OTL-200 to provide analysis
There is not enough data for OTL-200 to provide correlation calculation
There is not enough data for OTL-200 to provide analysis
There is not enough data for OTL-203 to provide analysis
There is not enough data for OTL-203 to provide correlation calculation
There is not enough data for OTL-203 to provide analysis
There is not enough data for OTL-201 to provide analysis
There is not enough data for OTL-201 to provide correlation calculation
There is not enough data for OTL-201 to provide analysis
There is not enough data for OTL-204 to provide analysis
There is not enough data for OTL-204 to provide correlation calculation
There is not enough data for OTL-204 to provide analysis
After 39 days of this quarter the interest is at 34.0. Based on that we can calculate that during remaining 52 days it will total up to 79.0. metachromatic leukodystrophy expected interest is significantly lower compared to previous quarter (-81.0%) and same quarter last year (-84.7%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 288 | 404 40.3% QoQ | 218 -46.0% QoQ | 358 64.2% QoQ |
| 2020 | 395 37.2% YoY 10.3% QoQ | 294 -27.2% YoY -25.6% QoQ | 373 71.1% YoY 26.9% QoQ | 303 -15.4% YoY -18.8% QoQ |
| 2021 | 368 -6.8% YoY 21.5% QoQ | 344 17.0% YoY -6.5% QoQ | 400 7.2% YoY 16.3% QoQ | 294 -3.0% YoY -26.5% QoQ |
| 2022 | 420 14.1% YoY 42.9% QoQ | 433 25.9% YoY 3.1% QoQ | 381 -4.8% YoY -12.0% QoQ | 412 40.1% YoY 8.1% QoQ |
| 2023 | 515 22.6% YoY 25.0% QoQ | 392 -9.5% YoY -23.9% QoQ | 340 -10.8% YoY -13.3% QoQ | 415 0.7% YoY 22.1% QoQ |
| 2024 | 34 -93.4% YoY -91.8% QoQ | - | - | - |
The average 5 years interest of metachromatic leukodystrophy was 28.28 per week. The last year interest of metachromatic leukodystrophy compared to the last 5 years has changed by 3.36%. The interest for metachromatic leukodystrophy is seasonal. The last year interest is comparable to 5 years ago. It has changed only by 5.91%.
After 34 days of this quarter the interest is at 79.0. Based on that we can calculate that during remaining 58 days it will total up to 214.0. adenosine deaminase deficiency expected interest is significantly higher compared to previous quarter (+289.1%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 89 |
| 2019 | 261 193.3% QoQ | 108 -58.6% QoQ | 140 29.6% QoQ | 267 200.0% YoY 90.7% QoQ |
| 2020 | 161 -38.3% YoY -39.7% QoQ | 139 28.7% YoY -13.7% QoQ | 171 22.1% YoY 23.0% QoQ | 76 -71.5% YoY -55.6% QoQ |
| 2021 | 137 -14.9% YoY 80.3% QoQ | 82 -41.0% YoY -40.1% QoQ | 100 -41.5% YoY 22.0% QoQ | 174 128.9% YoY 74.0% QoQ |
| 2022 | 296 116.1% YoY 70.1% QoQ | 243 196.3% YoY -17.9% QoQ | 113 13.0% YoY -53.5% QoQ | 181 4.0% YoY 60.2% QoQ |
| 2023 | 104 -64.9% YoY -42.5% QoQ | 218 -10.3% YoY 109.6% QoQ | 55 -51.3% YoY -74.8% QoQ | 79 -56.4% YoY 43.6% QoQ |
The average 5 years interest of adenosine deaminase deficiency was 12.28 per week. The last year interest of adenosine deaminase deficiency compared to the last 5 years has changed by -10.42%. This is something to be checked. The last year interest is quite lower compared to 5 years ago. It has decreased by -25.22%.
There is not enough data for mucopolysaccharidosis type I to provide analysis
There is not enough data for mucopolysaccharidosis type I to provide correlation calculation
There is not enough data for mucopolysaccharidosis type I to provide analysis
There is not enough data for mucopolysaccharidosis type IIIA to provide analysis
There is not enough data for mucopolysaccharidosis type IIIA to provide correlation calculation
There is not enough data for mucopolysaccharidosis type IIIA to provide analysis
There is not enough data for frontotemporal dementia with progranulin mutations to provide analysis
There is not enough data for frontotemporal dementia with progranulin mutations to provide correlation calculation
There is not enough data for frontotemporal dementia with progranulin mutations to provide analysis
There is not enough data for Crohn's disease with mutations to provide analysis
There is not enough data for Crohn's disease with mutations to provide correlation calculation
There is not enough data for Crohn's disease with mutations to provide analysis
After 39 days of this quarter the interest is at 86.0. Based on that we can calculate that during remaining 52 days it will total up to 201.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 134 | 212 58.2% QoQ | 256 20.8% QoQ | 202 -21.1% QoQ |
| 2020 | 203 51.5% YoY 0.5% QoQ | 194 -8.5% YoY -4.4% QoQ | 197 -23.0% YoY 1.5% QoQ | 189 -6.4% YoY -4.1% QoQ |
| 2021 | 202 -0.5% YoY 6.9% QoQ | 176 -9.3% YoY -12.9% QoQ | 191 -3.0% YoY 8.5% QoQ | 180 -4.8% YoY -5.8% QoQ |
| 2022 | 416 105.9% YoY 131.1% QoQ | 270 53.4% YoY -35.1% QoQ | 402 110.5% YoY 48.9% QoQ | 288 60.0% YoY -28.4% QoQ |
| 2023 | 233 -44.0% YoY -19.1% QoQ | 317 17.4% YoY 36.1% QoQ | 259 -35.6% YoY -18.3% QoQ | 213 -26.0% YoY -17.8% QoQ |
| 2024 | 86 -63.1% YoY -59.6% QoQ | - | - | - |
The average 5 years interest of hereditary angioedema was 18.47 per week. The last year interest of hereditary angioedema compared to the last 5 years has changed by 4.22%. This is something to be checked. The last year interest is comparable to 5 years ago. It has changed only by 11.72%.